Novel and complex dosage forms are transforming how therapies are delivered—improving patient compliance, extending therapeutic windows, and enabling drugs that would otherwise fail due to poor solubility or bioavailability. However, with innovation comes complexity: these drug products require specialized expertise, advanced formulation strategies, and tight regulatory alignment to transition from concept to clinic successfully.
At CMC Pharma, we provide end-to-end support for novel and complex dosage forms, leveraging deep formulation knowledge, state-of-the-art analytical development and execution, and embedded regulatory oversight. Our approach ensures innovative delivery systems are not just scientifically sound, but manufacturable, compliant, and submission-ready.
Each formulation is developed with scale-up and manufacturability in mind, avoiding the rework and delays that often hinder complex dosage form programs.
One of the most common pitfalls in developing complex dosage forms is a disconnect between laboratory execution and regulatory requirements. At CMC Pharma, our regulatory expertise and knowledge of manufacturing practices are embedded within the development process, ensuring:
This integrated model reduces risk, saves cost, and ensures your program stays on track for clinical entry and approval.
From solubilization technologies to long-acting injectables, CMC Pharma provides the expertise, execution speed, and regulatory integration that novel and complex dosage forms demand.
Partner with us to de-risk innovation, accelerate timelines, and bring advanced therapies to patients faster.
Whether you need to develop robust analytical methods or require routine testing. Contact CMC Pharma to learn how we can help you advance your development program.
Send us a message or give us a call at 440-485-1734.